Clinical Study — JCEM

https://pubmed.ncbi.nlm.nih.gov/14671183/

• Finasteride inhibits Type II only, reducing DHT ~70%.
  

• Dutasteride inhibits Type I and II, reducing DHT by 90–95%.
  

What this means for men:

Dutasteride protects more follicles, deeper follicles, and earlier-stage miniaturizing follicles that Finasteride can’t touch.

Clinical Study — Journal of the American Academy of Dermatology (JAAD)

https://pubmed.ncbi.nlm.nih.gov/24410939/

• 0.5 mg Dutasteride increased hair count 2.5–3× more than 1 mg Finasteride.
  

• Better global photography scores in ALL regions of the scalp.
  

• Patients and investigators both rated Dutasteride superior.
  

Layman’s translation:

Less shedding, thicker strands, and visible improvement — faster.

Clinical Study — JAAD finasteride-non-responder analysis

https://pubmed.ncbi.nlm.nih.gov/16546597/

• Many men who saw little to no benefit on Finasteride responded well to Dutasteride.
  

• Improvements in hair diameter, density, and hair count.
  

Why:

Finasteride leaves half the DHT pathway intact.

Dutasteride shuts the whole thing down.

Dutasteride Phase II Dose Trial

https://pubmed.ncbi.nlm.nih.gov/11807448/

• Visible thickening often begins around 3–4 months.
  

• Most men see measurable improvement by month 6.
  

This matters because:

Hair loss accelerates every year. Dutasteride slows — and often reverses — the process sooner.

You don’t need a less effective drug.

-

You need the medication with the strongest clinical backing and the highest likelihood of preserving and regrowing your hair.

-

So we cut out the noise and offer the single medication shown to:

• Reduce DHT more completely
  

• Improve hair count more dramatically
  

• Help men who didn’t respond to Finasteride
  

• Produce earlier and more noticeable changes
  

This is the JustOne™ philosophy —

One medication. One protocol. Real results.